Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Light-Chain Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04512235
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 281
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01222260
What this trial is testing

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Columbia University 40
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01864018
What this trial is testing

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

Who this might be right for
AmyloidosisPlasma Cell Myeloma
Mayo Clinic 87
Not applicableStudy completedNCT03431896
What this trial is testing

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Who this might be right for
AmyloidosisAmyloidAmyloid Neuropathies, Familial+4 more
The Cleveland Clinic 37
Not applicableStudy completedNCT03886155
What this trial is testing

Cardiac Amyloidosis Screening at Trigger Finger Release

Who this might be right for
AmyloidosisTrigger FingerTransthyretin Amyloidosis+1 more
The Cleveland Clinic 107
Testing effectiveness (Phase 2)Ended earlyNCT02590588
What this trial is testing

Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
John Mark Sloan 1
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Not applicableLooking for participantsNCT02641145
What this trial is testing

Molecular Imaging of Primary Amyloid Cardiomyopathy

Who this might be right for
Amyloidosis, PrimaryCardiomyopathy
Brigham and Women's Hospital 171
Not applicableLooking for participantsNCT07689331
What this trial is testing

Hungarian National Systemic Amyloidosis Registry

Who this might be right for
Systemic AmyloidosisATTR AmyloidosisAL Amyloidosis+1 more
Semmelweis University 300
Not applicableLooking for participantsNCT06192979
What this trial is testing

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Who this might be right for
Amyloidosis; SystemicAL Amyloidosis
Jin Lu, MD 41
Testing effectiveness (Phase 2)Study completedNCT00651937
What this trial is testing

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Who this might be right for
Multiple MyelomaPrimary Amyloidosis
M.D. Anderson Cancer Center 80
Early research (Phase 1)Study completedNCT01406314
What this trial is testing

SAP Depleter Dose Assessment Study in Patients

Who this might be right for
Amyloidosis
GlaxoSmithKline 17
Not applicableEnrolling By InvitationNCT07103863
What this trial is testing

Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis

Who this might be right for
AL Amyloidosis (AL)Cardiac Amyloidosis
Beijing Anzhen Hospital 49
Testing effectiveness (Phase 2)Study completedNCT01194791
What this trial is testing

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

Who this might be right for
Primary Systemic Amyloidosis
PETHEMA Foundation 30
Large-scale testing (Phase 3)Looking for participantsNCT06022939
What this trial is testing

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
SWOG Cancer Research Network 338
Not applicableLooking for participantsNCT07448779
What this trial is testing

Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment

Who this might be right for
AL AmyloidosisMGUSMultiple Myeloma+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia 100
Next Page